Alan C. Dalkin, M.D. - Endocrinology and Metabolism

Dr. Alan C. Dalkin is an internist who specializes in endocrinology and metabolism. He has a particular interest in the diagnosis and treatment of osteoporosis. He has been affiliated with the University of Virginia Health Sciences Center in Charlottesville, Virginia, since 1991 and was named Associate Professor of Internal Medicine in 1997.

Dr. Dalkin is active in scientific research and has coauthored book chapters, abstracts, and articles published in leading medical journals. He has presented dozens of papers and has been invited to speak at national and regional endocrinology conferences. In addition, he serves as an ad hoc reviewer of articles for the journals Clinical Chemistry, Clinical Endocrinology, and Endocrinology.

American Board of Internal Medicine—1987

ABIM Subspecialty in Endocrinology and Metabolism—1990

Hypothyroidism

Medical test topics related to Endocrinology, including Blood Glucose Test, Glucose Tolerance Test, and Bone Mineral Density

MD: University of Michigan Medical School, 1984

Internship and Residency in Internal Medicine, University of Chicago Hospitals, 1984–1987

Fellowship in Endocrinology and Metabolism, University of Michigan Medical Center, Ann Arbor, 1987–1990

University of Michigan Medical Center, Ann Arbor, Assistant Professor of Internal Medicine, 1990–1991

University of Virginia Health Sciences Center, Charlottesville, Division of Endocrinology and Metabolism, Dept. of Internal Medicine:

• Assistant Professor of Internal Medicine, 1991–1997
• Associate Professor of Internal Medicine, 1997–present

American College of Physicians

Endocrine Society

The Pituitary Society, Society for the Study of Reproduction

1. Prendergast KA, Burger LL, Aylor KW, Haisenleder DJ, Dalkin AC, Marshall JC (2004). Pituitary follistatin gene expression in female rats: Evidence that inhibin regulates transcription. Biology of Reproduction, 70(2): 364-370.
2. Haisenleder DJ, Burger LL, Aylor KW, Dalkin AC, Walsh HE, Shupnik MA, Marshall JC (2005). Testosterone stimulates FSH beta transcription via activation of extracellular signal-regulated kinase (ERK) in rat pituitary cells. Biology of Reproduction, 72(3): 523–529.
3. Heller H, Ward L, Shulman D, Kassem M, Rackoff P, Zimering M, Dalkin A, Drobney E, Colussi G, Shaker J, Hoogendorn E, Evans W, Econs MJ (2006). The sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia. Journal of Clinical Endocrinology and Metabolism, 91(6):2055-61.

1. Marshall JC, Haisenleder DJ, Dalkin AC, et al. (1991). Regulation of gonadotropin subunit gene expression. In Molecular and Clinical Advances in Pituitary Disorders, Current Issues in Endocrinology and Metabolism. Boston: Blackwell Scientific Publications.
2. Danenberg J, Dalkin AC (1992). Medical treatment of pituitary adenomas. In Surgical Pathology of the Pituitary Gland. Philadelphia: W.B. Saunders.
3. Corsi C, Dalkin AC (1996). Hyperprolactinemia. In Conn's Current Therapy. Philadelphia: W.B. Saunders.
4. Dalkin AC, Marshall JC (1997). Reproduction/Fertility (Inhibin/Activin: Regulation of Fertility). In Scientific Basis of Endocrinology: Fundamental and Clinical Principles. Totowa, NJ: Humana Press.

Dr. Dalkin is on the Speaker's Bureau for Merck & Co.